Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0211 | 0.5 | 0.5 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0211 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.0211 | 0.5 | 0.5 |
Plasmodium falciparum | esterase, putative | 0.0211 | 0.5 | 0.5 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.0211 | 0.5 | 0.5 |
Plasmodium vivax | PST-A protein | 0.0211 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0211 | 0.5 | 0.5 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0211 | 0.5 | 0.5 |
Leishmania major | monoglyceride lipase, putative | 0.0211 | 0.5 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0211 | 0.5 | 0.5 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.0211 | 0.5 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0211 | 0.5 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0211 | 0.5 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0211 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0211 | 0.5 | 0.5 |
Mycobacterium ulcerans | lysophospholipase | 0.0211 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0211 | 0.5 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0211 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0211 | 0.5 | 0.5 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0211 | 0.5 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0211 | 0.5 | 0.5 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.0211 | 0.5 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.